DK2220082T3 - Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester - Google Patents

Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester

Info

Publication number
DK2220082T3
DK2220082T3 DK08854867.2T DK08854867T DK2220082T3 DK 2220082 T3 DK2220082 T3 DK 2220082T3 DK 08854867 T DK08854867 T DK 08854867T DK 2220082 T3 DK2220082 T3 DK 2220082T3
Authority
DK
Denmark
Prior art keywords
azabicyclo
fluorophenyl
oct
ester
crystalline salt
Prior art date
Application number
DK08854867.2T
Other languages
English (en)
Inventor
Ruiz Juan Lorenzo Catena
Rodriguez José Hidalgo
Comas Maria Del Carmen Serra
Masip Isabel Masip
Original Assignee
Salvat Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salvat Lab Sa filed Critical Salvat Lab Sa
Application granted granted Critical
Publication of DK2220082T3 publication Critical patent/DK2220082T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK08854867.2T 2007-11-28 2008-11-26 Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester DK2220082T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07384038A EP2065385A1 (en) 2007-11-28 2007-11-28 Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester
PCT/EP2008/010012 WO2009068253A2 (en) 2007-11-28 2008-11-26 Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester

Publications (1)

Publication Number Publication Date
DK2220082T3 true DK2220082T3 (da) 2014-10-06

Family

ID=39401152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08854867.2T DK2220082T3 (da) 2007-11-28 2008-11-26 Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester

Country Status (19)

Country Link
US (2) US8492402B2 (da)
EP (2) EP2065385A1 (da)
JP (1) JP5336509B2 (da)
KR (1) KR101557832B1 (da)
CN (1) CN101925600B (da)
AU (1) AU2008329181B2 (da)
BR (1) BRPI0819607A2 (da)
CA (1) CA2706565C (da)
DK (1) DK2220082T3 (da)
EA (1) EA017483B1 (da)
ES (1) ES2498819T3 (da)
HK (1) HK1144192A1 (da)
IL (1) IL206032A (da)
MX (1) MX2010005850A (da)
NZ (1) NZ585833A (da)
PL (1) PL2220082T3 (da)
UA (1) UA102083C2 (da)
WO (1) WO2009068253A2 (da)
ZA (1) ZA201003718B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1345937T3 (da) 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
PT3150610T (pt) 2010-02-12 2019-11-11 Pfizer Sais e polrmorfos de 8-fluor0-2-{4- [(metilamino}metil]fenil}-1,3,4,5-tetrahidr0-6hazepin0[ 5,4,3-cd]indol-6-0na
KR101978364B1 (ko) 2017-06-15 2019-05-14 크리스탈지노믹스(주) 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE510305C2 (sv) * 1997-05-30 1999-05-10 Astra Ab Nytt salt
PT1300407E (pt) * 2000-06-27 2004-05-31 S A L V A T Lab Sa Compostos carbamatos derivados de arilalquilaminas
DK1345937T3 (da) * 2000-12-22 2006-01-16 Almirall Prodesfarma Ag Quinuclidincarbamatderivater og deres anvendelse som M3-antagonister
US7452904B2 (en) 2001-12-20 2008-11-18 Chiesi Farmaceutici S.P.A. 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2246170B1 (es) * 2004-07-29 2007-04-01 Almirall Prodesfarma, S.A. Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio.

Also Published As

Publication number Publication date
US20110207769A1 (en) 2011-08-25
PL2220082T3 (pl) 2014-12-31
KR20100103532A (ko) 2010-09-27
CN101925600B (zh) 2013-01-09
EA017483B1 (ru) 2012-12-28
IL206032A0 (en) 2010-11-30
US8871787B2 (en) 2014-10-28
CA2706565C (en) 2015-04-28
UA102083C2 (uk) 2013-06-10
IL206032A (en) 2014-07-31
EA201070651A1 (ru) 2010-12-30
WO2009068253A2 (en) 2009-06-04
US20140051721A1 (en) 2014-02-20
BRPI0819607A2 (pt) 2015-10-13
AU2008329181A1 (en) 2009-06-04
CN101925600A (zh) 2010-12-22
US8492402B2 (en) 2013-07-23
AU2008329181B2 (en) 2012-03-29
JP2011504890A (ja) 2011-02-17
EP2220082B1 (en) 2014-06-25
ES2498819T3 (es) 2014-09-25
CA2706565A1 (en) 2009-06-04
MX2010005850A (es) 2010-09-03
ZA201003718B (en) 2011-08-31
NZ585833A (en) 2011-05-27
EP2065385A1 (en) 2009-06-03
WO2009068253A3 (en) 2009-08-13
EP2220082A2 (en) 2010-08-25
HK1144192A1 (en) 2011-02-02
KR101557832B1 (ko) 2015-10-06
JP5336509B2 (ja) 2013-11-06

Similar Documents

Publication Publication Date Title
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
DK2117297T3 (da) Krystallinske komplekser af landbrugsmæssigt aktive organiske forbindelser
DK2350075T3 (da) Substituerede imidazo[1,2b]pyridazinforbindelser som trk-kinase-inhibitorer
ZA200904108B (en) Pyrido-pyrazine derivatives useful as herbicidal compounds
BRPI0814801A2 (pt) composto de piridazina cristalina
CR10693A (es) Enantiomerically pure phosphoindoles as hiv inhibitors
PT2004636E (pt) Compostos de enaminocarbonilo substituídos utilizados como insecticidas
BRPI1015540A2 (pt) ''composto de 1-cianoetil-heterociclilcarboxamida substituídos 750''
DK2069324T3 (da) Fusioneret aminopyridin som hsp90-inhibitorer
DK1937071T3 (da) Krystallinske modifikationer af pyraclostrobin
BRPI0910229A2 (pt) Tetramatos de 4';4'-dioxaspiro espirociclicamente substituídos
BRPI0922904A2 (pt) "compostos"
DK1874766T3 (da) Krystallinsk form af en quinolinon-carboxamid-forbindelse
IL177762A0 (en) Bimatoprost crystalline form i
BRPI0811994A2 (pt) " pistola automática ".
ATE513470T1 (de) Kristalline fipronil-modifikation
BRPI0622061A2 (pt) Composição virucidal
DE602006005232D1 (de) Konzentrierte Esterquat-zusammensetzung
DK2132204T3 (da) Krystalformer af en 8-azabicyclo[3.2.1]octanforbindelse
BRPI0820831A2 (pt) Combinações de composto ativo
BRPI0916395A2 (pt) compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
SE530154C8 (sv) Saltblandning
DK2220082T3 (da) Stabilt krystallinsk salt af (R)-3-fluorphenyl-3,4,5-trifluorbenzylcarbaminsyre-1-azabicyclo[2.2.2]oct-3-ylester
FR2909671B1 (fr) Procede de preparation de composes 1,3,2-oxazaborolidines
BRPI0818337A2 (pt) quimioterápico cristalino